Oral Antivirals for COVID-19: How to Best Make Use of Their Therapeutic Effects - Giovanni Di Perri, MD, PhD

Course on Clinical Pharmacology of SARS-CoV-2 Antivirals 2022

COVID-19 Vaccines - State of the Art - Kathryn Stephenson, MD, MPH

International Workshop on COVID-19 Vaccines 2022 - June Edition

Immune Correlates of Protection from SARS-CoV-2 Infection - Miles Davenport, MB BS, DPhil

International Workshop on COVID-19 Vaccines 2022 - June Edition

Infection Induced and Hybrid Immunity - Jefferson Jones

International Workshop on COVID-19 Vaccines 2022 - June Edition

COVID-19 Vaccination in Pregnant and Lactating Individuals - A. Collier, MD

International Workshop on COVID-19 Vaccines 2022 - June Edition

Thrombosis and COVID-19 Vaccination - S. Kerr, PhD

International Workshop on COVID-19 Vaccines 2022 - June Edition

Myocarditis and COVID-19 Vaccination - Biykem Bozkurt, MD, PhD, FHFSA, FACC, FAHA, FACP

International Workshop on COVID-19 Vaccines 2022 - June Edition

Intent to vaccinate against SARS-CoV-2 and its determinants across six ethnic groups living in Amsterdam, the Netherlands - Sophi Campman

International Workshop on COVID-19 Vaccines 2022 - June Edition

Binding Antibody Responses to SARS-CoV-2 Variants from Alpha to Omicron after BNT162b2 Vaccination and Booster in Infection - Jia Fu

International Workshop on COVID-19 Vaccines 2022 - June Edition

No Pain, More Gain - Microneedle Vaccines for COVID-19 and Influenza - Sharon Vijayanand

International Workshop on COVID-19 Vaccines 2022 - June Edition

Uptake and perceptions of COVID vaccine among people living with HIV in Zimbabwe - a cross sectional study - Paul Kambamura

International Workshop on COVID-19 Vaccines 2022 - June Edition

Operationalisation of Model for Dynamics of COVID-19 in Kenya - Trajectory of Omicron Wave in Kenya - Shem Sam

International Workshop on COVID-19 Vaccines 2022 - June Edition

Does Omicron Signal the End of the Pandemic? - Christina Pagel, Ph.D., M.Sc., M.Sc., M.A, M.A, B.A

COVID-19 Clinical Forum 2022

Vaccine Effectiveness Against the Omicron Variant - Anna Maria Geretti, MD, PhD, FRCPath

COVID-19 Clinical Forum 2022

Update on COVID-19 Therapeutics (March 2022 Edition) - D.Kuritzkes, MD

COVID-19 Clinical Forum 2022

How Will Technology Evolve Delivery Methods and Formulations - Eric Andrew Appel, PhD

International Workshop on Monoclonal Antibodies for HIV, COVID-19, and Oncology 2021

International Workshop on Monoclonal Antibodies fo-r HIV, COVID-19, and Oncology 2021 - Implementing Monoclonal Antibodies for Treatment and Prevention in Resource-Limited Settings - How to Make Them Affordable - David Ripin

International Workshop on Monoclonal Antibodies for HIV, COVID-19, and Oncology 2021

How Will Technology Evolve: Modification of Antibodies - Boris Juelg, MD, PhD

International Workshop on Monoclonal Antibodies for HIV, COVID-19, and Oncology 2021

How to Determine the Dosing (in Different Populations/Tissues) - Edmund Capparelli, PharmD

International Workshop on Monoclonal Antibodies for HIV, COVID-19, and Oncology 2021

Monoclonal Antibodies for Treatment in Hematologic Malignancies - Alison Moskowitz, MD

International Workshop on Monoclonal Antibodies for HIV, COVID-19, and Oncology 2021

Monoclonal Antibodies for Treatment in Autoimmune Diseases - Karmela Kim Chan, MD

International Workshop on Monoclonal Antibodies for HIV, COVID-19, and Oncology 2021

Monoclonal Antibodies for Prevention of HIV, COVID, and Ebola - Myron Cohen, MD, BS

International Workshop on Monoclonal Antibodies for HIV, COVID-19, and Oncology 2021

Monoclonal Antibodies for Treatment in COVID-19 - Florence Ader, Prof, MD

International Workshop on Monoclonal Antibodies for HIV, COVID-19, and Oncology 2021

Monoclonal Antibodies Against COVID-19: Targets, Development and Clinical Applications - Brigette Autran, MD, PhD

International Workshop on Monoclonal Antibodies for HIV, COVID-19, and Oncology 2021